Economic Burden of Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Economic Burden of Renal Cell Carcinoma

Published:2011-04 Issue:4 Volume:29 Page:315-329
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:Pharmacoeconomics

Author:

Shih Ya-Chen T.,Chien Chun-Ru,Xu Ying,Pan I-Wen,Smith Grace L.,Buchholz Thomas A.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

https://link.springer.com/content/pdf/10.2165/11586100-000000000-00000.pdf

Reference57 articles.

1. Wallen EM, Pruthi RS, Joyce GF, et al. Kidney cancer. J Urol 2007; 177 (6): 2006–18

2. Winer E, Gralow J, Diller L, et al. Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening: a report from the American Society of Clinical Oncology. J Clin Oncol 2009 Feb 10; 27 (5): 812–26

3. Jewett MA, Zuniga A. Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am 2008 Nov; 35 (4): 627–34

4. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) [online]. Available from URL: http://seer.cancer.gov/statfacts/html/kidrp.html [Accessed 2009 Sep 30]

5. National Comprehensive Cancer Network. Clinical practice guideline in oncology. Kidney cancer v.1.2010 [online]. Available from URL: http://www.nccn.org/professionals/physician_gls/PDF/kidney.pdf [Accessed 2009 Sep 18]

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of kidney cancer-related premature mortality and productivity loss in Greece and Portugal;Expert Review of Pharmacoeconomics & Outcomes Research;2023-03-01

2. Disparities in Clinical Care and Research in Renal Cell Carcinoma;Kidney Cancer;2022-11-18

3. Delaying Cancer Cases in Urology during COVID-19: Review of the Literature. Letter.;Journal of Urology;2021-05

4. Treatment sequences for advanced renal cell carcinoma: A health economic assessment;PLOS ONE;2019-08-29

5. Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II—An Updated Analysis of SEER-Medicare Data;PharmacoEconomics;2019-07-08